Amgen announced the opening of Amgen India, its new technology and innovation site in Hyderabad. The company plans to invest $200 million through 2025, with additional sustained investments planned over the coming years.
The site will accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines, while creating significant opportunities for local talent.
Robert A. Bradway, chairman and chief executive officer at Amgen, was joined by Anumula Revanth Reddy, Chief Minister of Telangana and D. Sridhar Babu, Minister of IT, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Government of Telangana, at the site opening.
“Amgen India is a reflection of our growth ambitions as well as an extension of our commitment to global health,” said Som Chattopadhyay, national executive for India at Amgen. “We are excited to contribute to the dynamic global biotech ecosystem from India and welcome the incredible talent pool the country offers.”
Naveen Gullapalli, managing director of Amgen India, emphasized the strategic value of the new site for the company’s global operations, stating: “Hyderabad is rapidly emerging as a global technology hub, and our new site is positioned at the heart of this landscape. Talent at Amgen India will drive global projects and initiatives, leveraging expertise across our global sites. Amgen India employees will bring bold, innovative thinking to help shape the future of global biotechnology from India.”
L-R: Ram Charan, Business Consultant, CEO & Author, Som Chattopadhay National Executive for India at Amgen, Jennifer Larson, U.S. General Consul, Hyderabad, D. Sridhar Babu, Minister of IT, E&C, I&C, LA, Anumula Revanth Reddy, Chief Minister of Telangana, Robert A. Bradway, Chairman & CEO, Amgen, Jayesh Ranjan, Special Chief Secretary, Dept. of Commerce & Industries, Govt. of Telangana, Naveen Gullapalli, Managing Director, Amgen India.
